MFG
ABBV icon

Mendota Financial Group’s AbbVie ABBV Stock Holding History

Mendota Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3
Closed -$593 – 376
2024
Q3 		$593 Buy
+3
New +$560 ﹤0.01% 370
2023
Q2 		– Sell
-100
Closed -$16.2K – 303
2023
Q1 		$16.2K Buy
+100
New +$15.3K 0.02% 200

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Mendota Financial Group's ABBV Position: Q4 2024 in Review

Mendota Financial Group sold out of AbbVie (ABBV) in Q4 2024, closing a stake of 3 shares — an estimated $593 sold.

Mendota Financial Group first reported a position in ABBV in Q1 2023 and held it in 2 quarters. The position peaked at $16.2K in Q1 2023. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Mendota Financial Group reported no remaining AbbVie position as of Q4 2024 after selling out during the quarter.
  • Mendota Financial Group sold 3 AbbVie shares in Q4 2024, an estimated $593.
  • Mendota Financial Group first reported a position in AbbVie in Q1 2023 and held it in 2 quarters.
  • Mendota Financial Group's AbbVie position peaked at $16.2K in Q1 2023.
  • 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Mendota Financial Group's 13F filing for Q4 2024, filed 14 Jan 2025.